Mar 19 Mar-18 Mar-17 Mar 16 Mar-15

12 mths 12 mths 12 mths 12 mths 12 mths

EQUITIES AND LIABILITIES

SHAREHOLDER'S FUNDS
Equity Share Capital 45.39 22.7 22.7 22.7 22.7
Total Share Capital 45.39 22.7 22.7 22.7 22.7
Reserves and Surplus 2019.01 1948.54 1689.86 1328.2 1189.46
Total Reserves and Surplus 2019.01 1948.54 1689.86 1328.2 1189.46
Total Shareholders Funds 2064.4 1971.24 1712.56 1350.9 1212.16
NON-CURRENT LIABILITIES
Long Term Borrowings 0 0 0 300 0
Deferred Tax Liabilities [Net] 15.49 13.94 29.71 0 12.39
Other Long Term Liabilities 30.58 34.11 12.82 14.68 16.3
Long Term Provisions 16.68 21.68 22.03 28.08 23.35
Total Non-Current Liabilities 62.75 69.73 64.56 342.76 52.04
CURRENT LIABILITIES
Short Term Borrowings 54.34 279.37 134.7 360 8.38
Trade Payables 224.99 184.34 148.62 185.76 126.58
Other Current Liabilities 145.33 74.7 356.8 57.44 58.51
Short Term Provisions 31.23 18.5 23.73 206.2 98.2
Total Current Liabilities 455.89 556.91 663.85 809.41 291.68
Total Capital And Liabilities 2583.04 2597.88 2440.97 2503.07 1555.87
ASSETS
NON-CURRENT ASSETS
Tangible Assets 1679.68 720.25 669.82 443.52 391.39
Intangible Assets 0 996.01 1237.66 1498.4 32.56
Capital Work-In-Progress 0 22.13 11.33 54.8 22.67
Intangible Assets Under Development 0 7.9 8.61 5.45 2.29
Other Assets 0 47.09 44.9 0 0
Fixed Assets 1679.68 1793.37 1972.32 2002.18 448.92
Non-Current Investments 179.17 187.26 94.83 7.08 7.08
Long Term Loans And Advances 9.71 8.16 3.43 109.4 40.88
Other Non-Current Assets 59.42 67.14 45.52 0.74 0.01
Total Non-Current Assets 1927.98 2055.93 2116.1 2119.39 496.89
CURRENT ASSETS
Current Investments 7.86 128.06 33.32 11.92 494.65
Inventories 213.54 183.85 169.2 143.14 118.45
Trade Receivables 142.25 70.03 34.13 52.01 56.9
Cash And Cash Equivalents 110.67 21.55 8.53 72.56 326.09
Short Term Loans And Advances 4.43 2.66 1.28 104.05 62.89
OtherCurrentAssets 176.31 135.8 78.41 0 0
Total Current Assets 655.06 541.95 324.88 383.68 1058.98
Total Assets 2583.04 2597.88 2440.97 2503.07 1555.87
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities 0 103.62 109.31 137.17 116.95
CIF VALUE OF IMPORTS
Raw Materials 0 30.18 0 21.07 9.25
Capital Goods 0 4.1 0 61.17 11.92
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency 0 5.74 0 6.17 5.95
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency - - - - -
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods - 98.45 - 100.64 100.48
Other Earnings - 7.84 - 1.32 0.55
BONUS DETAILS
Bonus Equity Share Capital - 13.18 13.18 13.18 13.18
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value - 152.32 94.36 32.54 34.17
Non-Current Investments Unquoted Book Value - 34.93 0.47 3.39 3.39
CURRENT INVESTMENTS
Current Investments Quoted Market Value - - - - -
Current Investments Unquoted Book Value - 128.06 33.32 11.93 496.51
Emami Previous Years »
Standalone Profit & Loss account ------------------- in Rs. Cr. -------------------

Income Statement (Emami) 2019 2018 2017 2016

Revenue From Operations [Gross] 2483.27 2323.44 2338.41 2426.21

Less: Excise/Sevice Tax/Other Levies 0 10.28 39.57 39.2
Revenue From Operations [Net] 2483.27 2313.17 2298.83 2387.01
Other Operating Revenues 0 40.82 2.88 4.5
Total Operating Revenues 2483.27 2353.99 2301.71 2391.51
Other Income 42.62 28.28 45.19 32.76
Total Revenue 2525.89 2382.27 2346.9 2424.27

EXPENSES
Cost Of Materials Consumed 743.03 629.15 607.38 606.22

Purchase Of Stock-In Trade 146.9 159.42 164.05 184.2

Changes In Inventories Of FG,WIP And Stock-In Trade -14.47 -10.48 -13.2 -20.09

Employee Benefit Expenses 237.29 215.94 194.96 172.44

Finance Costs 19.29 33.17 57.62 53.75

Depreciation And Amortisation Expenses 318.04 305.31 304.67 252.23

Other Expenses 669.51 660.51 609.51 793.78

Total Expenses 2119.59 1993.03 1924.99 2042.52

43525 43160 42795 42430

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 406.3 389.24 421.91 381.75
Exceptional Items -9.8 0 0 0
Profit/Loss Before Tax 396.5 389.24 421.91 381.75
Tax Expenses-Continued Operations
Current Tax 91.25 65.65 75.24 66.42
Less: MAT Credit Entitlement 0 -14 14 0
Deferred Tax 0 0.07 13.63 -12.39
Tax For Earlier Years 0 0 0.68 0.05
Total Tax Expenses 91.25 79.72 75.54 54.08
Profit/Loss After Tax And Before ExtraOrdinary Items 305.25 309.52 346.37 327.67
Profit/Loss From Continuing Operations 305.25 309.52 346.37 327.67
Profit/Loss For The Period 305.25 309.52 346.37 327.67

OTHER ADDITIONAL INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.) 6.72 13.64 15.26 14.44
Diluted EPS (Rs.) 6.72 13.64 15.26 14.44

VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS

Imported Raw Materials 0 0 0 8.93
Indigenous Raw Materials 0 0 0 597.29
STORES, SPARES AND LOOSE TOOLS
Indigenous Stores And Spares 0 0 0 2.75
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 0 119.16 198.6 158.88
Tax On Dividend 0 22.98 36.83 32.34
Equity Dividend Rate (%) 400 700 700 700
 2015

2066.07
39.53
2026.54
4.1
2030.64
95.82
2126.46

589.53

141.66

13.02

144.1

4.9

31.48

632.12

1556.81
42064

569.65
7.33
576.98

98.13
0
7.6
-0.38
105.35
471.63
471.63
471.63

20.78
20.78

5.93
583.6

2.48

158.88
29.29
700
Emami Previous Years »
Cash Flow ------------------- in Rs. Cr. -------------------
Mar 19 43160 42795 42430 42064

12 mths 12 mths 12 mths 12 mths 12 mths

Net Profit/Loss Before Extraordinary Items And Tax 0 389.24 421.91 381.75 576.98
Net CashFlow From Operating Activities 0 577.41 714.71 534.26 496.62
Net Cash Used In Investing Activities 0 -237.4 -260.55 -1298.74 -224.41
Net Cash Used From Financing Activities 0 -330.93 -518.57 502.99 -220.74
Foreign Exchange Gains / Losses 0 0 0 4.35 7.33
Net Inc/Dec In Cash And Cash Equivalents 0 9.08 -64.41 -257.14 58.81
Cash And Cash Equivalents Begin of Year 0 0.62 65.04 322.17 263.37
Cash And Cash Equivalents End Of Year 0 9.7 0.62 65.04 322.17
Dr Reddys Laboratories Previous Years »
Standalone Balance Sheet ------------------- in Rs. Cr. -------------------
Mar 19 43160 42795 42430 42064

12 mths 12 mths 12 mths 12 mths 12 mths

EQUITIES AND LIABILITIES

SHAREHOLDER'S FUNDS
Equity Share Capital 83 83 82.9 85.3 85.2
Total Share Capital 83 83 82.9 85.3 85.2
Reserves and Surplus 12601.1 11724.8 11517.7 11520.1 10548.8
Total Reserves and Surplus 12601.1 11724.8 11517.7 11520.1 10548.8
Total Shareholders Funds 12684.1 11807.8 11600.6 11605.4 10634
NON-CURRENT LIABILITIES
Long Term Borrowings 345.4 488 485.2 994.4 939.1
Deferred Tax Liabilities [Net] 55.5 0 0 35.5 129
Other Long Term Liabilities 28.5 31.3 41.1 57.1 25.5
Long Term Provisions 54.7 53.3 62.3 66.5 49.8
Total Non-Current Liabilities 484.1 572.6 588.6 1153.5 1143.4
CURRENT LIABILITIES
Short Term Borrowings 546.3 2100.8 1869.9 2089.6 2185.7
Trade Payables 1031.6 1061 778.7 719.2 716
Other Current Liabilities 1316.7 1384.7 1401 1409.5 1237.4
Short Term Provisions 184.7 173.4 208.4 580.4 539.5
Total Current Liabilities 3079.3 4719.9 4258 4798.7 4678.6
Total Capital And Liabilities 16247.5 17100.3 16447.2 17557.6 16456
ASSETS
NON-CURRENT ASSETS
Tangible Assets 5082.8 3979 4043.3 3593.8 3129.4
Intangible Assets 0 738.3 798.8 835.5 120
Capital Work-In-Progress 0 675 540 615 488.3
Fixed Assets 5082.8 5392.3 5382.1 5044.3 3737.7
Non-Current Investments 1819.1 1953.7 1802.8 1776.1 1760.1
Deferred Tax Assets [Net] 0 93.1 82.1 0 0
Long Term Loans And Advances 33.2 199.1 193.2 639.6 553.8
Other Non-Current Assets 68.6 423.6 393.2 2.7 1.1
Total Non-Current Assets 7003.7 8061.8 7853.4 7462.7 6052.7
CURRENT ASSETS
Current Investments 2114.4 1682.8 1299.1 2112.2 2102.2
Inventories 2015.6 1856.8 1809.7 1699.6 1723.3
Trade Receivables 3717.7 4203.8 4405.4 3893.5 4711.7
Cash And Cash Equivalents 113.2 120.7 66.8 1268 901.4
Short Term Loans And Advances 0 0 0 832.6 865.7
OtherCurrentAssets 1282.9 1174.4 1012.8 289 99
Total Current Assets 9243.8 9038.5 8593.8 10094.9 10403.3
Total Assets 16247.5 17100.3 16447.2 17557.6 16456
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities 0 721.1 940.6 972.6 1919.4
CIF VALUE OF IMPORTS
Raw Materials 0 0 0 1200.3 1151.2
Capital Goods 0 0 0 204.7 197.3
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency 0 1891.6 0 1306.5 1252.3

REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS

Dividend Remittance In Foreign Currency - - - - -
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods - 7262.3 - 7261.8 7414.6
Other Earnings - - - 278.7 72.4
BONUS DETAILS
Bonus Equity Share Capital - 55.87 55.87 55.87 55.87
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value - 3 3.5 2.3 3.2
Non-Current Investments Unquoted Book Value - 3700.9 3218.4 1968.8 1886.8
CURRENT INVESTMENTS
Current Investments Quoted Market Value - - - - 2142.2
Current Investments Unquoted Book Value - - - 2112.2 -
DR. REDDYS LABORATORIES

Income Statement
Current Years
Particulars 2019 2018 2017 2016
Revenue From Operations [Gross] 10466.7 9302.6 9628.1 10234.8
Less: Excise/Sevice Tax/Other Levies 0 0 0 84.2
Revenue From Operations [Net] 10466.7 9302.6 9628.1 10150.6
Other Operating Revenues 158.8 56.7 91.7 57.1
Total Operating Revenues 10625.5 9359.3 9719.8 10207.7
Other Income 238.4 204 591.2 244.8
Total Revenue 10863.9 9563.3 10311 10452.5
Growth% 14% -7% -1% 2%
EXPENSES
Cost Of Materials Consumed 2103.2 2011 1904.6 1988.5
Growth % of Revenue 19% 21% 18% 19%
Purchase Of Stock-In Trade 868.6 671.6 671.5 610.4
Growth % of Revenue 8% 7% 7% 6%
Operating And Direct Expenses 0 0 0 94.2
Growth % of Revenue 0% 0% 0% 1%
Changes In Inventories Of FG,WIP And Stock-In Trade 66 -51.6 1.9 -28.8
Growth % of Revenue 1% -1% 0% 0%
Employee Benefit Expenses 1931.9 1843 1803.3 1710
Growth % of Revenue 18% 19% 17% 16%
Finance Costs 56.8 62.8 57.2 63.8
Growth % of Revenue 1% 1% 1% 1%
Depreciation And Amortisation Expenses 780.6 774.1 735.1 649.1
Growth % of Revenue 7% 8% 7% 6%
Other Expenses 3356.1 3555.4 3592.9 3429.4
Growth % of Revenue 31% 37% 35% 33%
Total Expenses 9163.2 8866.3 8766.5 8516.6
Growth % of Revenue 84% 93% 85% 81%
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1700.7 697 1544.5 1935.9
Growth % of Revenue 16% 7% 15% 19%
Exceptional Items 0 0 0 -355.9
Growth % of Revenue 0% 0% 0% -3%
Profit/Loss Before Tax 1700.7 697 1544.5 1580
Growth % of Revenue 16% 7% 15% 15%
Tax Expenses-Continued Operations
Growth % of Revenue
Current Tax 423.4 138.1 182.6 416
Growth % of Revenue 4% 1% 2% 4%
Less: MAT Credit Entitlement 0 0 0 97
Growth % of Revenue 0% 0% 0% 1%
Deferred Tax 0 -8 -22.2 -93.5
Growth % of Revenue 0% 0% 0% -1%
Total Tax Expenses 423.4 130.1 160.4 225.5
Growth % of Revenue 4% 1% 2% 2%
Profit/Loss After Tax And Before ExtraOrdinary Items 1277.3 566.9 1384.1 1354.5
Growth % of Revenue 12% 6% 13% 13%
Profit/Loss From Continuing Operations 1277.3 566.9 1384.1 1354.5
Growth % of Revenue 12% 6% 13% 13%
Profit/Loss For The Period 1277.3 566.9 1384.1 1354.5
Growth % of Revenue 12% 6% 13% 13%
EARNINGS PER SHARE
Basic EPS (Rs.) 76.98 34.19 83.05 79.42
Growth % of Revenue 1% 0% 1% 1%
Diluted EPS (Rs.) 76.85 34.12 82.88 79.14
Growth % of Revenue 1% 0% 1% 1%
 2015
10010.4
82.9
9927.5
83.5
10011
222.8 2020 2021
10233.8 11057.6 11254.75
2%

2248.4 2208.287 2247.66

22% 20%
526.1 718.9868 731.8058
5% 7%
92.4 39.89824 40.6096
1% 0%
-28.9 -10.4284 -10.6143
0% 0%
1490.9 1890.22 1923.921
15% 17%
63.8 65.63925 66.80955
1% 1%
490.2 738.8473 752.0204
5% 7%
3291 3712.756 3778.952
32% 34%
8173.9 9364.206 9531.163
80% 85%
2059.9 1693.39 1723.582
20% 15%
0 0 0
0% -1%
2059.9 1618.09 1646.939
20% 15%

376.7 326.711 332.536

4% 3%
0 20.52307 20.88898
0% 0%
3.8 -25.5729 -26.0288
 0% 0%
380.5 280.615 285.6182
4% 3%
1679.4 1337.474 1361.321
16% 12%
1679.4 1337.474 1361.321
16% 12%
1679.4 1337.474 1361.321
16% 12%

99 79.58703 81.00601
1% 1%
98 79.23257 80.64524
1% 1%
Dr Reddys Laboratories Previous Years »
Cash Flow ------------------- in Rs. Cr. -------------------
Mar 19 43160 43160 42795 42795

12 mths 12 mths 12 mths 12 mths 12 mths

Net Profit/Loss Before Extraordinary Items And Tax 0 697 697 1544.5 1544.5
Net CashFlow From Operating Activities 0 1538.6 1538.6 1015.9 1015.9
Net Cash Used In Investing Activities 0 -1179.9 -1179.9 1442.5 1442.5
Net Cash Used From Financing Activities 0 -304.4 -304.4 -2581.8 -2581.8
Foreign Exchange Gains / Losses 0 -0.3 -0.3 -12 -12
Net Inc/Dec In Cash And Cash Equivalents 0 54 54 -135.4 -135.4
Cash And Cash Equivalents Begin of Year 0 66.7 66.7 202.1 202.1
Cash And Cash Equivalents End Of Year 0 120.7 120.7 66.7 66.7